Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
PYC Therapeutics Limited
(AU:PYC)
ASX
:PYC
PYC
PYC Therapeutics Limited
Overview
Analyst Forecasts
AI Stock Analysis
Popular
Dividends
Earnings
Financials
Statistics
New
Technical Analysis
Historical Prices
New
News & Insights
Chart
Drug Pipeline
More
RESEARCH TOOLS
Top Analyst Stocks
Top Smart Score Stocks
Stock Screener
reports
Download AU:PYC Report
Want to see AU:PYC full AI Analyst Report?
Download
PYC Therapeutics Limited (PYC) Stock News & Sentiment
Download AU:PYC Report
Follow
46
Followers
Premium
Company Announcements
PYC to unveil early clinical data on first-in-class gene-targeted eye drugs at ARVO
2d ago
PYC
Premium
Company Announcements
PYC Therapeutics Issues New Shares Following Option Exercise and Lodges Cleansing Notice
7d ago
PYC
Premium
Company Announcements
PYC Therapeutics Lists Additional 250,000 Shares on ASX
7d ago
PYC
Premium
Company Announcements
PYC Therapeutics Advances Genetic Disease Pipeline After $600m Capital Raise
8d ago
PYC
Premium
Company Announcements
PYC Wins EMA Orphan Status for RP11 Gene Therapy Candidate VP-001
9d ago
PYC
Premium
Company Announcements
PYC Therapeutics Wins Safety Nod to Advance ADOA Drug PYC-001 to Multi-Dose Trial
21d ago
PYC
Premium
Company Announcements
PYC Therapeutics CEO Increases Shareholding and Receives Major Option Grant
1M ago
PYC
More AU:PYC News >
PYC News on the Web
All News
Bearish News
Bullish News
2026-04-15
Canaccord Genuity Keeps Their Buy Rating on PYC Therapeutics Limited (PYC)
TipRanks News
Bullish
2026-04-15
Health Check: Orthocell dons the fatigues with US defence deal
StockHead
Neutral
2026-04-15
This ASX biotech stock just jumped again as its lead drug trial moves ahead
The Motley Fool
Neutral
2026-04-15
PYC Therapeutics Surges on Key Drug Trial Milestone
TipRanks News
Bullish
2026-04-15
PYC Therapeutics Wins Safety Nod to Advance ADOA Drug PYC-001 to Multi-Dose Trial
TipRanks News
Bullish
2026-04-01
Health Check: The biotech winners and losers from a messy March of mayhem
StockHead
Neutral
2026-03-27
PYC Therapeutics CEO Increases Shareholding and Receives Major Option Grant
TipRanks News
Bullish
2026-03-26
PYC Therapeutics to Showcase PKD Drug Progress at World Nephrology Congress
TipRanks News
Bullish
142
Results | Showing
1
out of
18
News Score - Last 7 Days
Very Positive
AU:PYC
Sector Average
Media Buzz
This Week
5 articles
Weekly Average
2 articles
News Sentiment
This Week
100%
Sector Average
70%
See how Bullish or Bearish a stock is based on its recent media coverage.
This score is generated using a formula that combines
Media Buzz
and
News Sentiment
.
Media Coverage Analysis
The historical news coverage of this asset in the last three months.
FAQ
What is AU:PYC’s Media Buzz Sentiment?
5 articles about AU:PYC were published this week. In an average week, 2 articles are published.
What is AU:PYC’s weekly average amount of articles?
In an average week, 2 articles about AU:PYC are published.
What is AU:PYC’s News Sentiment?
100% of articles about AU:PYC were positive this week, compared to its sector average of 70%.
Healthcare Stocks that are Trending in the News
TVTX
Travere Therapeutics
HVO
Open Orphan Plc
PBM
Psyence Biomedical
QDEL
QuidelOrtho
Showing the stocks with the most bullish news sentiment over the past week
See the stocks with the most bullish news sentiment in the sector
Upgrade Now
You need to enable JavaScript to run this app.